@article{scailteux:hal-03281779,
TITLE = {Hospitalization for adverse events under abiraterone or enzalutamide exposure in real-world setting: a French population-based study on prostate cancer patients},
AUTHOR = {Scailteux, Lucie-Marie and Despas, Fabien and Balusson, Fr{\'e}d{\'e}ric and Campillo-Gimenez, Boris and Mathieu, Romain and Vincendeau, S{\'e}bastien and Happe, Andr{\'e} and Nowak, Emmanuel and Kerbrat, Sandrine and Oger, Emmanuel},
URL = {https://hal.science/hal-03281779},
JOURNAL = {British Journal of Clinical Pharmacology},
PUBLISHER = {Wiley},
VOLUME = {88},
NUMBER = {1},
PAGES = {336-346},
YEAR = {2022},
MONTH = Jan, DOI = {10.1111/bcp.14972},
KEYWORDS = {abiraterone ; acute kidney injury ; adverse events ; castration-resistant prostate cancer ; enzalutamide ; liver test monitoring ; safety},
PDF = {https://hal.science/hal-03281779/file/Scailteux%20et%20al%20-%202021%20-%20Hospitalization%20for%20adverse%20events%20under%20abiraterone%20or%20enzalutamide%20exposure.pdf},
HAL_ID = {hal-03281779},
HAL_VERSION = {v1},
}